Find clinical trials for Prostate Cancer in Nashville, TN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Nashville, TN, USA:
Assessment of the safety and efficacy of HLD-0915 in patients with metastatic prostate cancer who have progressed on prior systemic ...
Phase 1, Phase 2
Nashville, Tennessee, United States and 11 other locations
and in combination with abiraterone in participants with metastatic prostate cancer. The study includes dose-escalation and cohort ...
Phase 1, Phase 2
Nashville, Tennessee, United States and 16 other locations
This Phase 2, open-label, multicenter study is conducted in patients with castration-resistant prostate cancer.Patients in this stu ...
Phase 2
Nashville, Tennessee, United States and 13 other locations
pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...
Phase 1
Nashville, Tennessee, United States and 35 other locations
Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potentia ...
Phase 1
Nashville, Tennessee, United States and 25 other locations
ANDROMEDA is a first-in-human, Phase I/II, open-label, multicenter study of AZD9750 in participants with metastatic prostate cancer...
Phase 1, Phase 2
Nashville, Tennessee, United States and 17 other locations
The aim for this study is to investigate the ability of 64Cu-SAR-bisPSMA PET/CT to detect recurrence of prostate cancer...
Phase 3
Nashville, Tennessee, United States and 24 other locations
this trial is to determine the safety profile of xaluritamig at the proposed regimen in adult participants with metastatic castration-resistant prostate...
Phase 1
Nashville, Tennessee, United States and 10 other locations
The overall aim of the trial is to evaluate the safety, tolerability, and pharmacokinetics (PK) of AMG 509 (monotherapy and in combination with abira...
Phase 1
Nashville, Tennessee, United States and 57 other locations
The purpose of this study is to evaluate the safety, efficacy, tolerability, and pharmacokinetics (PK) of FG-3246, a cluster of differentiation 46 (C...
Phase 2
Nashville, Tennessee, United States and 22 other locations
Clinical trials
Research sites
Resources
Legal